TVM Capital Healthcare has announced a €16M investment into Munich-based neurocare, a digital therapy platform for mental health treatment.
Neurocare provides treatment for a variety of psychological or neurological conditions. Following a detailed assessment of the patient's condition, neurocare supports clinicians in developing individualized therapy plans that are designed to lead to strong, sustainable clinical outcomes.
Globally, 12.9% of people are affected by mental disorders, causing tremendous direct and indirect costs, expected to increase from $2.5 trillion in 2010 to $6 trillion by 2030. The number of patients diagnosed with mental illnesses doubled during the COVID pandemic.
The treatment of mental health conditions remains nevertheless significantly lacking in most countries, leaving a considerable portion of the population without the necessary support, and presenting a unique growth opportunity for companies like neurocare.
Thomas Mechtersheimer, Founder and CEO of neurocare group, added: “We are very pleased to announce the cooperation with TVM Capital Healthcare, a strong partner with deep industry experience. This partnership allows us to accelerate neurocare’s growth in our key markets in the US, Europe and Australia and expand our geographic footprint into new regions.
“The implementation of our Digital Therapy Platform into clinics in the MENA region represents a new milestone in our company's growth. I want to thank all involved parties, especially bm-t Thüringen, Aescuvest and Goerg Lawyers, for their advice and support in closing this financing."
Would you like to write the first comment?
Login to post comments